Reboxetine Plus Oxybutynin for OSA Treatment

Elisa Perger; Luigi Taranto‐Montemurro; Débora Rosa; Stefano Vicini; Mariapaola Marconi; L Zanotti; P. Meriggi; Ali Azarbarzin; Scott A. Sands; Andrew Wellman; Carolina Lombardi; Gianfranco Parati

doi:10.1016/j.chest.2021.08.080

Article2021

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment

Elisa Perger, Luigi Taranto‐Montemurro, Daniela Santoro Rosa, Stefano Vicini, Manuel Marconi, L Zanotti, P. Meriggi, Ali Azarbarzin, Scott A. Sands, Andrew Wellman, Carolina Lombardi, Gianfranco Parati

Article2023

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation

Elisa Perger, Paolo Castiglioni, Andrea Faini, Davide Soranna, Antonella Zambon, Débora Rosa, Stefano Vicini, P. Meriggi, Laura Pini, Claudia Baratto, Sergio Caravita, Ali Azarbarzin, Gianfranco Parati, Carolina Lombardi

Article2021

Impact of Reboxetine plus Oxybutynin treatment for Obstructed Sleep Apnea on the Cardiovascular Autonomic Activity

Elisa Perger, Paolo Castiglioni, Débora Rosa, Stefano Vicini, P. Meriggi, Andrea Faini, Laura Pini, Luigi Taranto‐Montemurro, Carolina Lombardi, Gianfranco Parati

Article2015

Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia

Hertzel C. Gerstein, Guillaume Paré, Matthew McQueen, Heinz Haenel, Shun Fu Lee, Janice Pogue, Aldo Maggioni, Salim Yusuf, Sibylle Hess

Article2021

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment <br>A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover&nbsp;Trial

Elisa Perger, Luigi Taranto‐Montemurro, Débora Rosa, Stefano Vicini, Mariapaola Marconi, Lucia Zanotti, P. Meriggi, Ali Azarbarzin, Scott A. Sands, Andrew Wellman, Carolina Lombardi, Gianfranco Parati

Reboxetine Plus Oxybutynin for OSA Treatment

Abstract

Discussion(0)

Related publications

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation

Impact of Reboxetine plus Oxybutynin treatment for Obstructed Sleep Apnea on the Cardiovascular Autonomic Activity

Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment <br>A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover&nbsp;Trial

Reboxetine Plus Oxybutynin for OSA Treatment

Abstract

Discussion(0)

Related publications

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation

Impact of Reboxetine plus Oxybutynin treatment for Obstructed Sleep Apnea on the Cardiovascular Autonomic Activity

Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment &lt;br&gt;A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover&amp;nbsp;Trial

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment <br>A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover Trial